on a mobile?
vTap
    Loading...
 
suggest
 
Video
UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of avian flu.
2 years ago
BBC News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Go to Feed to see what's new!
share
keep
 
 
Jean-...GlaxoSmithKline Plc, talks with Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris ...
8 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Chief executive officer
Pharmaceutical company
Mergers and acquisitions
Rosiglitazone
Cervarix
Lapatinib
Go to Feed to see what's new!
share
keep
 
 
Jean-...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Pharmaceutical company
Chief executive officer
Go to Feed to see what's new!
share
keep
 
 
CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.
11 months ago
The New York Times
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
CNBC
Pharmaceutical company
Go to Feed to see what's new!
share
keep
 
 
A look at the pharma giant's earnings forecast for the year ahead, with Jean-Pierre Garnier, GlaxoSmithKline CEO and CNBC's Mike Huckman
3m 35s |
11 months ago
CNBC Video Gallery - CNBC.com
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
CNBC
Go to Feed to see what's new!
share
keep
 
 
More Videos
 
Keep this video in the "Saved" list
Go to Feed to see what's new!
share
keep
 
 
 
 
GlaxoSmithKline CEO Jean-Pierre Garnier discusses his company's earnings and timeline for�bringing the bird-flu vaccine to market.
2 years ago
The Wall Street Journal
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
GlaxoSmithKline
Go to Feed to see what's new!
share
keep
 
 

Corporate Home Corporate Home News FAQ About Contact Forums Send Feedback
Privacy Policy and Terms of Use